ADVERTISEMENT

Watch Related Video

Pharma Exports Witness Significant Growth: A Boost to the Indian Pharma Industry

The Indian pharma industry has shown remarkable resilience and growth, with pharma exports growing by 9.4% to $30.47 billion in FY25. This significant increase in pharmaceutical exports is a testament to the industry's capabilities and its potential for further expansion. The pharma sector growth is expected to continue, with the industry eyeing double-digit expansion by 2026-27.

Pharma Exports: A Key Driver of Growth

Pharma exports have been a key driver of growth for the Indian pharma industry, with the sector witnessing a steady increase in exports over the years. The growth in pharmaceutical exports can be attributed to the industry's focus on quality, innovation, and competitiveness. The Indian pharma industry has been able to capitalize on the growing demand for pharmaceuticals globally, with many Indian companies emerging as major players in the international market.

Indian Pharma Industry: A Global Player

The Indian pharma industry has evolved into a global player, with many Indian companies having a significant presence in international markets. The industry's growth has been driven by its ability to provide high-quality pharmaceuticals at competitive prices. The Indian pharma industry has also been able to leverage its strengths in research and development, manufacturing, and marketing to emerge as a major player in the global pharmaceutical market.

FY25 Exports: A New Milestone

The growth in pharma exports in FY25 is a significant milestone for the Indian pharma industry. The industry's ability to achieve double-digit growth in exports is a testament to its resilience and capabilities. The growth in pharmaceutical exports is expected to continue, with the industry eyeing new markets and opportunities for expansion.

Pharma Sector Growth: A Positive Outlook

The outlook for the pharma sector is positive, with the industry expected to continue its growth trajectory. The growth in pharma exports is expected to be driven by the increasing demand for pharmaceuticals globally, as well as the industry's focus on quality, innovation, and competitiveness. The Indian pharma industry is well-positioned to capitalize on the growing demand for pharmaceuticals, with many Indian companies having a significant presence in international markets.

Key Takeaways:

• Pharma exports grew by 9.4% to $30.47 billion in FY25
• The Indian pharma industry is eyeing double-digit expansion by 2026-27
• The growth in pharma exports is driven by the industry's focus on quality, innovation, and competitiveness
• The Indian pharma industry has emerged as a major player in the global pharmaceutical market

Conclusion:

The growth in pharma exports is a significant milestone for the Indian pharma industry. The industry's ability to achieve double-digit growth in exports is a testament to its resilience and capabilities. With the industry eyeing double-digit expansion by 2026-27, the outlook for the pharma sector is positive. As the Indian pharma industry continues to grow and evolve, it is likely to play an increasingly important role in the global pharmaceutical market.

What are your thoughts on the growth of the Indian pharma industry? Share your feedback with us.

---

🇮🇳 हिंदी में पढ़ें (News in Hindi)

हिंदी समाचार

भारतीय फार्मा उद्योग में वृद्धि देखी गई है, जिसमें फार्मा निर्यात में 9.4% की वृद्धि हुई है और यह 30.47 अरब डॉलर तक पहुंच गया है। यह वृद्धि फार्मा क्षेत्र की वृद्धि का एक महत्वपूर्ण मील का पत्थर है।

---

🇧🇩 বাংলায় পড়ুন (News in Bengali)

বাংলা সংবাদ

ভারতীয় ফার্মা শিল্পে বৃদ্ধি দেখা যাচ্ছে, যেখানে ফার্মা রফতানি 9.4% বেড়েছে এবং এটি 30.47 বিলিয়ন ডলারে পৌঁছেছে। এই বৃদ্ধি ফার্মা সেক্টরের বৃদ্ধির একটি গুরুত্বপূর্ণ মাইলফলক।